Anhui Anke Biotechnology (Group) Co., Ltd. (SHE:300009)
China flag China · Delayed Price · Currency is CNY
8.86
+0.07 (0.80%)
May 8, 2026, 3:04 PM CST

SHE:300009 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash & Equivalents
174.5250.2299.18260.23324.59322.56
Short-Term Investments
64.86141.07----
Trading Asset Securities
1,4181,1921,1451,196842.91805.43
Cash & Short-Term Investments
1,6581,5831,4441,4561,1671,128
Cash Growth
38.37%9.65%-0.82%24.70%3.50%26.10%
Accounts Receivable
495.8495.56492.35597.44476.3543.89
Other Receivables
49.9635.1630.54911.2546.96
Receivables
545.76530.73522.9606.44487.55590.85
Inventory
274.22252.75297.3235.22210.48181.25
Other Current Assets
31.8728.3611.0328.0345.0221.53
Total Current Assets
2,5102,3952,2752,3251,9111,922
Property, Plant & Equipment
1,6021,6251,5841,4341,176881.34
Long-Term Investments
813.56789.28515.54404.38347.89188.09
Goodwill
66.5666.5666.5666.5657.657.6
Other Intangible Assets
385.72393.66412.32450.36275.64126.22
Long-Term Deferred Tax Assets
60.1461.541.829.5341.851.22
Long-Term Deferred Charges
208.91204.8223.28223.8413.28386.18
Other Long-Term Assets
17.7812.1517.1517.134.4156.81
Total Assets
5,6655,5485,1354,9514,2573,669
Accounts Payable
207.5252.28215.02211.7151.01141.11
Accrued Expenses
110.4255.35238.6328.25240.6306.76
Short-Term Debt
--5-3-
Current Portion of Leases
7.827.6610.718.816.083.3
Current Income Taxes Payable
77.2556.3958.2243.9146.8893.12
Current Unearned Revenue
13.258.0919.3424.4327.9619.51
Other Current Liabilities
167.3259.93120.69229.98200.2762.99
Total Current Liabilities
583.55639.7667.59847.08675.8626.79
Long-Term Leases
22.4225.2938.2547.8224.0623.74
Long-Term Unearned Revenue
125.27123.43121.53113.52114.16107.18
Long-Term Deferred Tax Liabilities
26.5320.578.0510.0141.147.81
Other Long-Term Liabilities
2.312.31----
Total Liabilities
760.07811.3835.411,018855.17765.52
Common Stock
1,6711,6731,6731,6771,6731,638
Additional Paid-In Capital
449.39459.5508.66519.82405.73186.87
Retained Earnings
2,5442,3762,0581,7671,337961.26
Treasury Stock
-8.32-14.55-114.57-226.22-207.41-
Comprehensive Income & Other
87.0364.76----
Total Common Equity
4,7434,5584,1243,7373,2092,787
Minority Interest
161.09178.34175.63194.93193.09116.97
Shareholders' Equity
4,9054,7364,3003,9323,4022,904
Total Liabilities & Equity
5,6655,5485,1354,9514,2573,669
Total Debt
30.2432.9653.9656.6333.1427.04
Net Cash (Debt)
1,6271,5501,3901,3991,1341,101
Net Cash Growth
41.84%11.54%-0.66%23.35%3.03%25.04%
Net Cash Per Share
0.980.930.830.840.690.69
Filing Date Shares Outstanding
1,6761,6661,6781,6611,5891,638
Total Common Shares Outstanding
1,6761,6661,6781,6611,5891,638
Working Capital
1,9261,7551,6081,4781,2351,295
Book Value Per Share
2.832.742.462.252.021.70
Tangible Book Value
4,2914,0983,6453,2202,8752,603
Tangible Book Value Per Share
2.562.462.171.941.811.59
Buildings
-767.14545.04583.06564.87469.79
Machinery
-809.14760.51624.66562.37528.17
Construction In Progress
-620.77799.75672.51445.68228.75
Source: S&P Global Market Intelligence. Standard template. Financial Sources.